Sanlan Wu

743 total citations
37 papers, 538 citations indexed

About

Sanlan Wu is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Sanlan Wu has authored 37 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in Sanlan Wu's work include Lung Cancer Treatments and Mutations (6 papers), Antifungal resistance and susceptibility (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Sanlan Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Antifungal resistance and susceptibility (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Sanlan Wu collaborates with scholars based in China, United States and Australia. Sanlan Wu's co-authors include Yu Zhang, Peng Cao, Qilin Zhang, Tingting Wu, Kaiping Wang, Ziyong Sun, Jiangeng Huang, Haishan Huang, Fei Wang and Guoqing Tang and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sanlan Wu

35 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanlan Wu China 14 194 139 89 69 69 37 538
Mohamed N. Amin Egypt 14 167 0.9× 198 1.4× 57 0.6× 99 1.4× 33 0.5× 31 654
Renbin Huang China 13 175 0.9× 146 1.1× 41 0.5× 149 2.2× 55 0.8× 32 590
YU Xue-ying China 5 223 1.1× 178 1.3× 59 0.7× 103 1.5× 33 0.5× 9 517
Ben Liu China 14 187 1.0× 317 2.3× 97 1.1× 105 1.5× 38 0.6× 25 887
Saiedeh Razi Soofiyani Iran 13 170 0.9× 314 2.3× 41 0.5× 78 1.1× 33 0.5× 30 773
Mina Kelleni Egypt 10 109 0.6× 118 0.8× 100 1.1× 56 0.8× 34 0.5× 33 434
Xiaojie Yan China 10 227 1.2× 110 0.8× 61 0.7× 118 1.7× 23 0.3× 35 482
Molly M. Gilligan United States 7 132 0.7× 216 1.6× 70 0.8× 65 0.9× 25 0.4× 11 705
Manasvi Gupta United States 12 90 0.5× 142 1.0× 53 0.6× 49 0.7× 39 0.6× 28 685
Maria Tsoumani Greece 20 113 0.6× 230 1.7× 98 1.1× 76 1.1× 24 0.3× 48 903

Countries citing papers authored by Sanlan Wu

Since Specialization
Citations

This map shows the geographic impact of Sanlan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanlan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanlan Wu more than expected).

Fields of papers citing papers by Sanlan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanlan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanlan Wu. The network helps show where Sanlan Wu may publish in the future.

Co-authorship network of co-authors of Sanlan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sanlan Wu. A scholar is included among the top collaborators of Sanlan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanlan Wu. Sanlan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mei, Chao, Tian Wang, Sanlan Wu, et al.. (2024). Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study. BMC Pulmonary Medicine. 24(1). 167–167. 1 indexed citations
3.
4.
Cao, Peng, Sanlan Wu, Yixin Hu, et al.. (2023). Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: Role of FXR and Nrf2 pathways. Food and Chemical Toxicology. 178. 113914–113914. 12 indexed citations
5.
Zhang, Yan, Tingting Wang, Sanlan Wu, et al.. (2023). Notch signaling pathway: a new target for neuropathic pain therapy. The Journal of Headache and Pain. 24(1). 87–87. 18 indexed citations
6.
Mei, Chao, Weijing Gong, Xu Wang, et al.. (2023). Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine. Frontiers in Pharmacology. 14. 1147717–1147717. 17 indexed citations
7.
Wu, Sanlan, Weijing Gong, Peng Cao, et al.. (2022). Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization. Frontiers in Pharmacology. 12. 730826–730826. 7 indexed citations
8.
Cao, Peng, et al.. (2022). Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients. Frontiers in Pharmacology. 13. 954242–954242. 1 indexed citations
9.
Xu, Hua, et al.. (2021). Model-Oriented Dose Optimization of Voriconazole in Critically Ill Children. Antimicrobial Agents and Chemotherapy. 65(9). e0049321–e0049321. 15 indexed citations
10.
11.
Gong, Weijing, Tao Zhou, Sanlan Wu, et al.. (2021). A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19. Journal of Infection and Chemotherapy. 27(6). 876–881. 27 indexed citations
12.
Wu, Sanlan, et al.. (2021). Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole. Pharmacogenomics and Personalized Medicine. Volume 14. 1379–1389. 7 indexed citations
13.
Gong, Weijing, Tao Zhou, Sanlan Wu, et al.. (2021). A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma. Annals of Translational Medicine. 9(18). 1484–1484. 8 indexed citations
14.
Shu, Chang, et al.. (2021). Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children. Frontiers in Pharmacology. 11. 614164–614164. 9 indexed citations
15.
Zhou, Jun, et al.. (2020). The impact of surgical margin status on prostate cancer-specific mortality after radical prostatectomy: a systematic review and meta-analysis. Clinical & Translational Oncology. 22(11). 2087–2096. 10 indexed citations
16.
Gong, Weijing, Liyun Ma, Hu Lei, et al.. (2019). STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy. International Journal of Clinical Oncology. 24(5). 476–484. 13 indexed citations
17.
Li, Dan, Gang Zhao, Li Gao, et al.. (2018). Simultaneous LC‐MS/MS bioanalysis of etoposide and paclitaxel in mouse tissues and plasma after oral administration of self‐microemulsifying drug‐delivery systems. Biomedical Chromatography. 32(6). e4192–e4192. 6 indexed citations
18.
19.
Li, Kang, Luqin Si, Dan Li, et al.. (2017). Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes. Toxicology in Vitro. 40. 313–323. 30 indexed citations
20.
Si, Luqin, Li Gao, Sanlan Wu, et al.. (2008). Disposition and tissue distribution of ML12 in rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(2). 125–127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed N. Amin Breakdown of academic impact, for papers by Renbin Huang Breakdown of academic impact, for papers by YU Xue-ying Breakdown of academic impact, for papers by Ben Liu Breakdown of academic impact, for papers by Saiedeh Razi Soofiyani Breakdown of academic impact, for papers by Mina Kelleni Breakdown of academic impact, for papers by Xiaojie Yan Breakdown of academic impact, for papers by Molly M. Gilligan Breakdown of academic impact, for papers by Manasvi Gupta Breakdown of academic impact, for papers by Maria Tsoumani
Rankless by CCL
2026